- ►siemens.com [PDF] P Greenland, L LaBree, SP Azen, TM Doherty … - Jama, 2004 - Am Med Assoc Context Guidelines advise that all adults undergo coronary heart disease (CHD)
risk assessment to guide preventive treatment intensity. Although the Framingham
Risk Score (FRS) is often recommended for this, it has been suggested that ... Cited by 652 - Related articles - BL Direct - All 14 versions
- ►zhaoys.com [PDF] R Andraws, JS Berger, DL Brown - Jama, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 61 - Related articles - All 10 versions
JS Forrester, PK Shah - The American journal of cardiology, 2006 - Elsevier High-density lipoprotein cholesterol is a potent and independent epidemiologic
risk factor and is a proved antiatherosclerotic agent in animal models of
atherosclerosis, acting through the principal mechanisms of accelerating ... Cited by 32 - Related articles - All 14 versions
RA Kreisberg, A Oberman - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc Atherosclerosis is a complex multifactorial disease. Lipids play an important,
but not an exclusive, role in its development and progression. In some persons,
lipids will be a major factor, and in some, lipids as we currently ... Cited by 32 - Related articles - BL Direct - All 5 versions
EM Balk, RH Karas, HS Jordan, B Kupelnick, … - The American journal of medicine, 2004 - Elsevier Statins decrease the progression and increase the regression of coronary artery
lesions and luminal narrowing. Compared with placebo, statins decrease the
likelihood of coronary artery restenosis (summary risk ratio = 0.85; 95% ... Cited by 32 - Related articles - All 9 versions
JS Forrester, P Libby - The American journal of cardiology, 2007 - Elsevier Inflammatory cytokines have a central role in atherogenesis and plaque rupture.
These mediators, including tumor necrosis factor, interleukins, and matrix
metalloproteinases and transforming growth factor-β are also prominent in ... Cited by 35 - Related articles - All 12 versions
A Clerico - Clinical chemistry and laboratory medicine, 2003 - reference-global.com The practice of cardiology continues to evolve along with a better understanding
of the pathophysiology of cardiovascular disease and the development of new
therapeutic procedures. Consequently, new demands are being made on the in ... Cited by 17 - Related articles - BL Direct - All 8 versions
CM Gibson, AJ Kirtane, SA Murphy, J Karha … - Journal of thrombosis and thrombolysis, 2003 - Springer Abstract. Background: Shorter distances from the coronary ostia to culprit
lesions have been associated with a higher incidence of adverse outcomes in ST
el- evation acute myocardial infarction (STEMI). As drug- eluting stents ... Cited by 16 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org BK Ray, A Shakya, JR Turk, SS Apte, A Ray - Circulation research, 2004 - Am Heart Assoc Based on epidemiological and pathological studies, it is becoming increasingly
clear that matrix metalloproteinases (MMPs) play an important role in the
pathogenesis of atherosclerosis by participating in vascular remodeling, ... Cited by 12 - Related articles - BL Direct - All 7 versions
- ►critcaremed.com S Vittorini, A Clerico - Clinical Chemistry and Laboratory Medicine, 2008 - reference-global.com The practice of cardiology is in continual evolution, in parallel with the
progress achieved by medical research in understanding the pathophysiology of
cardiovascular disease and in developing new thera- peutic procedures. ... Cited by 10 - Related articles - All 9 versions
